The culprit behind amyloid beta peptide related neurotoxicity in Alzheimer's disease: oligomer size or conformation?

Alzheimer's Research & Therapy
Kerensa BroersenJoost Schymkowitz

Abstract

Since the reformulation of the amyloid cascade hypothesis to focus on oligomeric aggregates of amyloid beta as the prime toxic species causing Alzheimer's disease, many researchers refocused on detecting a specific molecular assembly of defined size thatis the main trigger of Alzheimer's disease. The result has been the identification of a host of molecular assemblies containing from two up to a hundred molecules of the amyloid beta peptide, which were all found to impair memory formation in mice. This clearly demonstrates that size is insufficient to define toxicity and peptide conformation has to be taken into account. In this review we discuss the interplay between oligomer size and peptide conformation as the key determinants of the neurotoxicity of the amyloid beta peptide.

References

Apr 10, 1992·Science·J A Hardy, G A Higgins
May 21, 1992·Nature·S ChoeD Eisenberg
Mar 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·V S AlluredD B McKay
May 1, 1995·Neurobiology of Aging·D W DicksonP Davies
Oct 1, 1995·European Journal of Biochemistry·H StichtP Rösch
Nov 15, 1994·Biochemical and Biophysical Research Communications·T OdaC E Finch
Mar 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·W J StrittmatterA D Roses
Apr 12, 1996·The Journal of Biological Chemistry·L O TjernbergC Nordstedt
Feb 23, 1996·The Journal of Biological Chemistry·Y M KuoA E Roher
Feb 1, 1997·Chemistry & Biology·J D HarperP T Lansbury
Aug 29, 1997·The Journal of Biological Chemistry·D M WalshD B Teplow
May 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·M P LambertW L Klein
Aug 28, 1999·The Journal of Biological Chemistry·D M WalshD B Teplow
Aug 15, 2000·Journal of Structural Biology·S ZhangJ P Lee
Dec 2, 2000·Nature Structural Biology·Y FezouiD B Teplow
Dec 6, 2000·Protein Science : a Publication of the Protein Society·M BouchardC V Robinson
Jan 13, 2001·The Journal of Biological Chemistry·Y KallbergJ Johansson
Apr 23, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Bruno PermanneClaudio Soto
Oct 26, 2002·Science·Dennis J Selkoe
Nov 9, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Hyeon-Jin KimSeong-Tshool Hong
Dec 31, 2002·Proceedings of the National Academy of Sciences of the United States of America·Gal BitanDavid B Teplow
Aug 20, 2003·Proceedings of the National Academy of Sciences of the United States of America·Yuesong GongWilliam L Klein
Nov 5, 2003·Biochemistry·Brett A ChromyWilliam L Klein
Feb 18, 2004·Current Protein & Peptide Science·Yann Verdier, Botond Penke
May 11, 2004·The Journal of Biological Chemistry·Monica BucciantiniMassimo Stefani
May 19, 2004·The European Journal of Neuroscience·Igor KlyubinMichael J Rowan

❮ Previous
Next ❯

Citations

Mar 27, 2013·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Gregor P Lotz, Justin Legleiter
Jul 3, 2013·Archives of Pharmacal Research·Jaehyung Koo, Youngjoo Byun
May 15, 2013·Molecular Neurodegeneration·Jungsu KimChristopher Janus
Nov 19, 2013·PloS One·Hélène VignaudChristophe Cullin
Feb 17, 2011·Immunotherapy·Salim Shah, Howard J Federoff
Jun 5, 2013·Nanomedicine·Gholamreza Hassanzadeh-GhassabehSerge Muyldermans
Jul 9, 2013·Journal of Neurotrauma·Niklas MarklundLars Hillered
May 8, 2014·Cellular and Molecular Life Sciences : CMLS·E HubinK Pauwels
Jul 22, 2014·Alzheimer's Research & Therapy·William F GoureFranz Hefti
May 15, 2013·Immunity & Ageing : I & a·Jens MorethKatharina Schindowski
Oct 1, 2015·ACS Chemical Neuroscience·Robin RoychaudhuriDavid B Teplow
Mar 18, 2016·Journal of Biological Physics·Maryam Hashemi ShabestariMartina Huber
Jul 21, 2015·Cellular and Molecular Life Sciences : CMLS·Ellen HubinRabia Sarroukh
Jul 19, 2015·CNS Drugs·Andreas SoejitnoThomas Eko Purwata
Apr 9, 2015·Frontiers in Chemistry·Eleonora CerasoliBrian M Austen
Nov 12, 2014·Journal of Molecular Neuroscience : MN·Keren Nicole HamishaGadi Turgeman
Oct 31, 2014·Cellular and Molecular Life Sciences : CMLS·Ryan C McCarthy, Daniel J Kosman
Feb 12, 2013·Neurochemistry International·Ann TiimanVello Tõugu
Jan 30, 2020·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·John M Sanderson
Apr 22, 2017·Frontiers in Neuroscience·Aaron Ciechanover, Yong Tae Kwon
Nov 12, 2014·BioMed Research International·Panchanan MaitiSally Frautschy
Oct 17, 2019·Frontiers in Neuroscience·Teresa UbinaPaul M Salvaterra

❮ Previous
Next ❯

Methods Mentioned

BETA
nuclear magnetic resonance
NMR
immunodepletion
atomic
electrophoresis
AFM
size exclusion chromatography
light
circular dichroism
X-ray

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.